In 2025, two major regulatory bodies issued independent but complementary warnings that have renewed clinical scrutiny of this medication. Finasteride, a 5α-reductase inhibitor, has been a cornerstone therapy for male pattern hair loss (1 mg daily) and benign prostatic hyperplasia (5 mg daily) for over two decades. While effective and widely prescribed, finasteride is not […]
CAMPAIGN RUN BY
Brook is a trading name of Brook Young People. Limited company registered in England and Wales, number 2466940. Registered Charity in England and Wales, number 703015. Registered Charity in Scotland, number SC045788.
The Family Planning Association is a registered charity, number 250187, and a limited liability company registered in England, number 887632.
FPA, 23-28 Penn Street, London N1 5DL
Brook, 81 London Road, Liverpool L3 8JA
© 2013-23 Brook and FPA - Powered by Winona eSolutions
